Notably, pSTAT3 has been recognized as a key regulator of PD-L1 in the immune microenvironment in BC [60]; in this context, the current results corroborate our previous finding that PD-L1 expression also prevails on the PBMCs of early-BC patients [26]. This evidence concerns the gene CD274 and breast cancer.